Manchester-based life sciences company Phagenesis has closed a 7 million Euro (US$9.23 million) second round of funding to accelerate its commercialisation strategy. Phagenesis Ltd, is a specialist in ...

NASHVILLE, Tenn., April 29, 2026 /PRNewswire/ -- Phagenesis, a commercial-stage company pioneering neuromodulation therapies for swallowing disorders, today announced the appointment of Stephen N.

MANCHESTER, England, March 4, 2024 /PRNewswire/ -- Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a $42M ...

The Nestle logo is pictured on the company headquarters entrance building in Vevey, Switzerland February 18, 2016. REUTERS/Pierre Albouy - RTX27GML ZURICH (Reuters) - Nestle (NESN.S) announced a deal ...

Biotechnology firm Phagenesis has secured £1m to increase the use of its pioneering treatment for stroke victims. The Manchester-based company has created a device to treat patients who are dysphagic ...

MANCHESTER University healthcare technology spin-out Phagenesis has secured £6m venture capital funding. Phagenesis, based on Manchester Science Park, has developed a device that helps people who have ...

Nestlé SA has struck a deal to buy a U.K.-based maker of a device to treat dysphagia, a condition in which people have difficulty swallowing, marking its latest medically focused investment. Terms of ...

Biotechnology business Phagenesis today announced it has secured a £6m funding boost to accelerate its development plans. Phagenesis, which was spun out of Manchester University in 2007, is pioneering ...

Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a $42M Series D financing all equity investment round. The ...